Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists

Details for Australian Patent Application No. 2002246726 (hide)

Owner Bristol-Myers Squibb Company

Inventors Mitchell, Ian, S.; Fevig, John, M.; Chen, Wenting; Lee Taekyu; Cacciola, Joseph

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002246726

PCT Pub. Number WO2002/059124

Priority 60/256,745 20.12.00 US

Filing date 19 December 2001

Wipo publication date 6 August 2002

Acceptance publication date 1 March 2007

International Classifications

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4745 (2006.01)

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 1/14 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

C07D 471/16 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 498/14 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 498/16 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-B-2002246726

1 March 2007 Application Accepted

  Published as AU-B-2002246726

28 June 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002246727-SITE-SPECIFIC IN SITU GENERATION OF ALLICIN USING A TARGETED ALLIINASE DELIVERY SYSTEM FOR THE TREATMENT OF CANCERS, TUMORS, INFECTIOUS DISEASES AND OTHER ALLICINSENSITIVE DISEASES

2002246725-Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands